Leidos, the lead team member on the Hanford Site’s support services contractor, is offering employees who don’t want to take a COVID-19 vaccination the option of moving over to the commercial side of the business, CEO Roger Krone said this week on a conference call.
Based on vaccination cards turned into the company, Krone said Leidos has a vaccination rate of more than 90%. That does not count all the employees at joint-venture companies at Department of Energy nuclear sites, which besides Hanford Mission Integration
Solutions include Consolidated Nuclear Security, the Bechtel National-led team that manages the Pantex Plant and the Y-12 National Security Site, where Leidos is a junior partner.
As for the company’s third quarter earnings, Leidos posted a net income of about $208 million — up about 25% compared with $163 million a year ago — on nearly $3.5 billion in quarterly revenue, up some 7.5% from about $3.2 billion last year. On a per share basis, third-quarter earnings came in at $1.43 a share, up from $1.13 a share, the company reported.
Meanwhile at the mothership, Krone said Tuesday that it could take the company months to lay off employees who refuse to either apply for an exemption to President Joe Biden’s vaccine mandate for federal contractors. The company worries that it has a “small percentage number of people” who won’t apply for an exemption or take a vaccination, Krone said.
Leidos embarked on an ambitious persuasion campaign for its employees, offering those who took a vaccine a chance to win a year’s salary. Ten people who took vaccines won the prize, Krone said on the call with investors.
Exchange Monitor affiliate publication Defense Daily contributed to this report.
